Takeda’s Zika vaccine gets U.S. FDA’s ‘fast track’ status (via U.S.)

Japan’s Takeda Pharmaceutical Co Ltd said on Monday the U.S. Food and Drug Administration had granted ‘fast track’ status to its vaccine for the mosquito-borne Zika virus, which erupted as a major public hazard in Brazil three years ago.

Source: U.S.